瑞财经刘治颖 3月18日，博雅生物(SZ300294)发布2024年年度报告，出现增利不增收情形。 2024年，博雅生物实现营业总收入17.35亿元，较上年同期减少34.58% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback